KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
In response to the health crisis, international agencies such as the World Health Organization are assisting local teams with logistics, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use protocol while observational data on its efficacy against the circulating viral strain is being collected by researchers. As part of the response, DR Congo has launched an Ebola vaccination campaign, with health workers intensifying ring-vaccination strategies around infection clusters to help contain the virus.
Health Officials Focus Ervebo Vaccines on Medical Staff in Kisangani
Operational challenges have arisen due to complex regional infrastructure, ongoing security concerns, and high population mobility across border districts. Kisangani has established cold-chain networks necessary to keep the vaccines at ultra-low temperatures before they are transported to more remote health zones. The government has initiated Ebola vaccination efforts alongside civil defense and community health workers conducting outreach programs to enhance disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are actively working with local response units to monitor adverse reactions and assess immune responses among vaccinated populations. Early detection, combined with isolation and supportive treatments, remains crucial for improving patient survival rates. Additional vaccine shipments are planned as distribution broadens to secondary health districts across the region.
Authorities Reinforce Rigorous Infection Prevention Measures in Treatment Facilities
National teams continue expanding contact-tracing initiatives across urban and rural zones in the eastern part of the country. Health centers at the municipal level are supplied with personal protective equipment, diagnostic reagents, and treatment supplies to strengthen readiness. The government has confirmed that comprehensive public health protocols will remain in place until viral transmission rates show consistent decline across all affected provinces.
The government has urged local communities to fully cooperate with mobile vaccination teams and adhere to established sanitary guidelines. It is anticipated that increasing immunization efforts among high-risk populations will help stabilize infection rates in the coming weeks. Surveillance systems will continue heightened monitoring at transportation hubs and border crossings to prevent further spread geographically.